+39 02 00660214
+39 02 00660216
Roberto Rizzi obtained the Ph.D. in Psychobiology and Psychopharmacology in 2003 at the University “La Sapienza” of Rome, working at the laboratories of the National Research Council (CNR). He carried out the first postdoctoral period at New York Medical College (NYMC) in Valhalla (NY, USA) dealing with the identification and characterization of cardiac progenitor cells. Subsequently, he moved to Boston (MA, USA) at the Harvard Medical School (Brigham and Women’s Hospital) where he was involved in the study of post-infarct remodeling and in cardiac cell therapy. Back in Italy, he gained a five years researcher position at the Institute of Cell Biology and Neurobiology of the CNR, where he developed an important know-how in the field of induced pluripotent stem cells (iPSC) related to cardiac and muscular personalized medicine. In 2017 he held a permanent researcher position at the CNR. The effort of his research activitiy regards the macro area of regenerative medicine using epigenetic, genetic and cellular approaches in the panorama of muscular and neurodegenerative pathologies. In particular, the core is the characterization of the role of immune system cells in conditioning the extracellular matrix (ECM) in neurodegenerative and muscular genetic diseases. The study of these mechanisms is supported by the employment of advanced technologies in the field of biomedicine, such as 3D bio-printing, and the use of bio-hydrogels derived from the decellularized extracellular matrix (dECM) of experimental models and patients suffering from genetic disorders (Duchenne muscular dystrophy, Amyotrophic Lateral Sclerosis). In 2019 he joined the National Institute of Molecular Genetics in Milan, as group leader of the Regenerative Medicine laboratory.